Biological Risk Factors for Onset of Binge Eating and Compensatory Behaviors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03687346 |
|
Recruitment Status :
Completed
First Posted : September 27, 2018
Last Update Posted : November 3, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Eating Disorder |
Participants will be adolescent girls aged 13-16, some of whom will have parental history of eating pathology. Participants will be recruited from the general population but their age, gender, and the presence of parental lifetime eating pathology will create a high-risk sample. The goals of the proposed project are to (1) conduct a prospective high-risk study to test whether proposed biological risk factors predict the future onset of core ED symptoms (e.g., binge eating, compensatory behaviors); (2) test hypotheses regarding how these biological risk factors and established self-report ED risk factors may work together to predict ED behavior onset; (3) examine if certain biological factors account for the effects of certain established self-reported ED risk factors (e.g., elevated brain response to thin models accounts for the effect of questionnaire-measured thin-ideal internalization). The participants will complete a baseline assessment and then follow-ups assessments over a span of three years. In addition, participants will complete one fMRI scan after the first assessment.
During the COVID-19 shelter-at-home order, the investigators will not measure in person only outcomes including fMRI scans, height and weight measurement for BMI calculation nor IAT computer paradigms for all participants that have assessments due during this order.
| Study Type : | Observational |
| Actual Enrollment : | 88 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Biological Risk Factors for Onset of Binge Eating and Compensatory Behaviors |
| Actual Study Start Date : | August 3, 2017 |
| Actual Primary Completion Date : | October 1, 2021 |
| Actual Study Completion Date : | October 1, 2021 |
| Group/Cohort |
|---|
|
High Risk Group
Parental history of eating pathology
|
|
Low Risk Group
No parental history of eating pathology
|
- Change in binge eating behaviors using the EDDI [ Time Frame: 6 months, 1 year, 2 year, and 3 year follow-up ]Eating Disorder Diagnostic Interview (EDDI)
- Change in compensatory behaviors using the EDDI [ Time Frame: 6 months, 1 year, 2 year, and 3 year follow-up ]Eating Disorder Diagnostic Interview (EDDI)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 13 Years to 16 Years (Child) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
-
Inclusion Criteria:
- Female
- Aged 13-16 years
-
Exclusion Criteria:
- Adolescents who report functional magnetic resonance imaging (fMRI) contraindications
- Current Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5) substance abuse disorder, eating disorder (ED), conduct disorder, attention deficit hyperactivity disorder (ADHD), or bipolar disorder
- Weekly or greater use of psychoactive drugs (e.g., analgesics, cocaine, marijuana)
- Serious medical complications (e.g., cancer, diabetes)
- History of head injury
- Relevant food allergies
- BMI > 35
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03687346
| United States, Oregon | |
| Oregon Research Institute | |
| Eugene, Oregon, United States, 97403 | |
| Principal Investigator: | Eric Stice, Ph.D. | Stanford University |
| Responsible Party: | Oregon Research Institute |
| ClinicalTrials.gov Identifier: | NCT03687346 |
| Other Study ID Numbers: |
BioRF Pilot |
| First Posted: | September 27, 2018 Key Record Dates |
| Last Update Posted: | November 3, 2021 |
| Last Verified: | November 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
fMRI Eating disorder adolescent |
|
Bulimia Feeding and Eating Disorders Mental Disorders Hyperphagia Signs and Symptoms, Digestive |

